Clostridium difficile infection (CDI) in children due to hypervirulent strains PCR-ribotype 027: An emblematic report of two cases

Anaerobe

Volumn 36, Issue , 2015, Pages 91-93

  Spigaglia, Patrizia ^a   Barbanti, Fabrizio ^a   Castagnola, Elio ^b   Bandettini, Roberto ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Antibiotics; C. difficile; Children; GVHD; HSCT; PCR ribotype 027

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CASE REPORT; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; FEMALE; HUMAN; ITALY; MALE; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RIBOTYPING; SCHOOL CHILD; CLASSIFICATION; CLOSTRIDIUM INFECTION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; POLYMERASE CHAIN REACTION; VIRULENCE;

ADOLESCENT; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; ITALY; MALE; POLYMERASE CHAIN REACTION; RIBOTYPING; VIRULENCE;

EID: 84948761828     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.09.004     Document Type: Article

References (20)

1. Deshpande A., Pant C., Anderson M.P., Donskey C.J., Sferra T.J. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence. Pediatr. Infect. Dis. J. 2013, 32:1138-1140.
2. Toltzis P., Kim J., Dul M., Zoltanski J., Smathers S., Zaoutis T. Presence of the epidemic North American pulsed field type 1 Clostridium difficile strain in hospitalized children. J. Pediatr. 2009, 154:607-608.
3. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., McDonald L.C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
4. Spigaglia P., Barbanti F., Morandi M., Moro M.L., Mastrantonio P. Aspetti microbiologici delle infezioni da Clostridium difficile in Italia: risultati di uno studio condotto negli anni 2012-2013. Microbiol. Medica 2014, 29:4722.
5. Indra A., Huhulescu S., Schneeweis M., Hasenberger P., Kernbichler S., Fiedler A., Wewalka G., Allerberger F., Kuijper E.J. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J. Med. Microbiol. 2008, 57:1377-1382.
6. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, 24th Informational Supplement M100-S24 2014, CLSI, Wayne, PA, USA.
7. Debast S.B., Bauer M.P., Kuijper E.J., European Society of Clinical Microbiology and Infectious Diseases European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 2014, 20:1-26.
8. Walk S.T., Micic D., Jain R., Lo E.S., Trivedi I., Liu E.W., Almassalha L.M., Ewing S.A., Ring C., Galecki A.T., Rogers M.A., Washer L., Newton D.W., Malani P.N., Young V.B., Aronoff D.M. Clostridium difficile ribotype does not predict severe infection. Clin. Infect. Dis. 2012, 55:1661-1668.
9. Kamboj M., Xiao K., Kaltsas A., Huang Y.T., Sun J., Chung D., Wu S., Sheahan A., Sepkowitz K., Jakubowski A.A., Papanicolaou G. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. Biol. Blood Marrow Transpl. 2014, 20:1626-1633.
10. Slimings C., Riley T.V. Antibiotics and hospital-acquired Clostridium difficile -associated diarrhoea: a systematic review. J. Antimicrob. Chemother. 2013, 51:1339-1350.
11. Dial S., Delaney J.A.C., Schneider V., Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile -associated disease defined by prescription for oral vancomycin therapy. CMAJ 2006, 175:745-748.
12. Bobak D., Arfons L.M., Creger R.J., Lazarus H.M. Clostridium difficile -associated disease in human stem cell transplant recipients: coming epidemic or false alarm?. Bone Marrow Transpl. 2008, 42:705-713.
13. Rodemann J.F., Dubberke E.R., Reske K.A., Seo H., Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2007, 5:339-344.
14. Castagnola E., Battaglia T., Bandettini R., Caviglia I., Baldelli I., Nantron M., Moroni C., Garaventa A. Clostridium difficile -associated disease in children with solid tumors. Support Care Cancer 2009, 17:321-324.
15. Sandora T.J., Fung M., Flaherty K., Helsing L., Scanlon P., Potter-Bynoe G., Gidengil C.A., Lee G.M. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr. Infect. Dis. J. 2011, 30:580-584.
16. Muto C.A., Pokrywka M., Shutt K., Mendelsohn A.B., Nouri K., Posey K., Roberts T., Croyle K., Krystofiak S., Patel-Brown S., Pasculle A.W., Paterson D.L., Saul M., Harrison L.H. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect. Control Hosp. Epidemiol. 2005, 26:273-280.
17. Freeman J., Vernon J., Morris K., Nicholson S., Todhunter S., Longshaw C., Wilcox M.H. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clin. Microbiol. Infect. 2015, 21:248. Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes' Study Group, e9-248.e16.
18. Pépin J., Alary M.E., Valiquette L., Raiche E., Ruel J., Fulop K., Godin D., Bourassa C. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin. Infect. Dis. 2005, 40:1591-1597.
19. Peláez T., Cercenado E., Alcalá L., Marín M., Martín-López A., Martínez-Alarcón J., Catalán P., Sánchez-Somolinos M., Bouza E. Metronidazole resistance in Clostridium difficile is heterogeneous. J. Clin. Microbiol. 2008, 46:3028-3032.
20. Trifilio S.M., Pi J., Mehta J. Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation. Biol. Blood Marrow Transpl. 2013, 19:405-409.